Literature DB >> 2164470

Molecular cloning and expression of glycogen synthase kinase-3/factor A.

J R Woodgett1.   

Abstract

Glycogen synthase kinase-3 (GSK-3) is a protein-serine kinase implicated in the hormonal control of several regulatory proteins including glycogen synthase and the transcription factor c-jun. Two classes of rat brain cDNA for this enzyme have been isolated termed GSK-3 alpha and GSK-3 beta. The alpha-type encodes a 51 kd polypeptide, the sequence of which includes all of the tryptic peptides determined by protein sequence analysis of purified skeletal muscle GSK-3. The novel beta-type cDNA has the potential to encode a 47 kd protein with 85% amino acid identity to GSK-3 alpha. The two types of cDNA are the products of distinct genes as determined by genomic organization and nucleic acid sequence analysis. Both alpha and beta clones exhibit kinase activity when expressed in COS-1 cells and type-specific antibodies to GSK-3 alpha and beta detect proteins of 51 and 47 kd, respectively, in a variety of rat tissue extracts, with highest levels of both in brain. Partial purification of GSK-3 activity from bovine brain results in the isolation of active alpha and beta proteins. The physiological importance of these two proteins in cellular signal transduction is discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2164470      PMCID: PMC552268          DOI: 10.1002/j.1460-2075.1990.tb07419.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  36 in total

Review 1.  Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins.

Authors:  P J Mitchell; R Tjian
Journal:  Science       Date:  1989-07-28       Impact factor: 47.728

2.  The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene.

Authors:  S A Ness; A Marknell; T Graf
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

3.  Use of peptide substrates for affinity purification of protein-serine kinases.

Authors:  J R Woodgett
Journal:  Anal Biochem       Date:  1989-08-01       Impact factor: 3.365

4.  Purification and characterization of protein phosphatase 1I activating kinase from bovine brain cytosolic and particulate fractions.

Authors:  H Y Tung; L J Reed
Journal:  J Biol Chem       Date:  1989-02-15       Impact factor: 5.157

Review 5.  Protein kinase C--a family affair.

Authors:  P J Parker; G Kour; R M Marais; F Mitchell; C Pears; D Schaap; S Stabel; C Webster
Journal:  Mol Cell Endocrinol       Date:  1989-08       Impact factor: 4.102

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase.

Authors:  N Embi; D B Rylatt; P Cohen
Journal:  Eur J Biochem       Date:  1980-06

8.  Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase.

Authors:  D B Smith; K S Johnson
Journal:  Gene       Date:  1988-07-15       Impact factor: 3.688

Review 9.  The structure and regulation of protein phosphatases.

Authors:  P Cohen
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  410 in total

Review 1.  GSK-3: tricks of the trade for a multi-tasking kinase.

Authors:  Bradley W Doble; James R Woodgett
Journal:  J Cell Sci       Date:  2003-04-01       Impact factor: 5.285

2.  NFAT/Fas signaling mediates the neuronal apoptosis and motor side effects of GSK-3 inhibition in a mouse model of lithium therapy.

Authors:  Raquel Gómez-Sintes; José J Lucas
Journal:  J Clin Invest       Date:  2010-06-07       Impact factor: 14.808

3.  Activation of glycogen synthase kinase-3 beta mediates β-amyloid induced neuritic damage in Alzheimer's disease.

Authors:  B DaRocha-Souto; M Coma; B G Pérez-Nievas; T C Scotton; M Siao; P Sánchez-Ferrer; T Hashimoto; Z Fan; E Hudry; I Barroeta; L Serenó; M Rodríguez; M B Sánchez; B T Hyman; T Gómez-Isla
Journal:  Neurobiol Dis       Date:  2011-09-13       Impact factor: 5.996

4.  Selectively silencing GSK-3 isoforms reduces plaques and tangles in mouse models of Alzheimer's disease.

Authors:  David E Hurtado; Laura Molina-Porcel; Jenna C Carroll; Caryn Macdonald; Awo K Aboagye; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

5.  Regulation of GSK3 isoforms by phosphatases PP1 and PP2A.

Authors:  Félix Hernández; Elena Langa; Raquel Cuadros; Jesús Avila; Nieves Villanueva
Journal:  Mol Cell Biochem       Date:  2010-07-22       Impact factor: 3.396

6.  First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines.

Authors:  Isela García; Yagamare Fall; Generosa Gómez; Humberto González-Díaz
Journal:  Mol Divers       Date:  2010-10-08       Impact factor: 2.943

7.  Inhibition of GSK-3 induces differentiation and impaired glucose metabolism in renal cancer.

Authors:  Krishnendu Pal; Ying Cao; Irina N Gaisina; Santanu Bhattacharya; Shamit K Dutta; Enfeng Wang; Hendra Gunosewoyo; Alan P Kozikowski; Daniel D Billadeau; Debabrata Mukhopadhyay
Journal:  Mol Cancer Ther       Date:  2013-12-10       Impact factor: 6.261

8.  Effects of the Ras homolog Rhes on Akt/protein kinase B and glycogen synthase kinase 3 phosphorylation in striatum.

Authors:  L M Harrison; S H Muller; D Spano
Journal:  Neuroscience       Date:  2013-02-01       Impact factor: 3.590

9.  GSK3β inhibition protects the immature brain from hypoxic-ischaemic insult via reduced STAT3 signalling.

Authors:  Barbara D'Angelo; C Joakim Ek; Yanyan Sun; Changlian Zhu; Mats Sandberg; Carina Mallard
Journal:  Neuropharmacology       Date:  2015-09-15       Impact factor: 5.250

Review 10.  Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders.

Authors:  J R Woodgett
Journal:  Curr Drug Targets Immune Endocr Metabol Disord       Date:  2003-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.